Cellomics expands European operations through user group implementation and expanded support groups
Cellomics, Inc. announced the expansion of their European training, service and support operations. As part of this expanded European focus, Cellomics has added new people and new programs to its repertoire of support services for Europe.
An example of new programs being executed in Europe was seen last week in London where Cellomics personnel held the first-ever European User Group meeting. This meeting featured attendance by more than 60 scientists who are utilizing HCS technologies across Europe, and included talks from five different scientists that highlighted various biological applications utilizing HCS to further their drug discovery and cell-based assay efforts. In addition, Cellomics employees from both Europe and North America participated to discuss such items as biology-focused forums, effective implementation of HCS across various therapeutic groups, usability improvements, and future trends.
In addition to the User Group, Cellomics' is pleased to announce an expansion of the European Sales, Service and Support organization. "New employees have been hired to help support our customers from the feasibility/evaluation stage all the way through to the assay development, training and productivity stages of HCS implementation." Commented David Sharp, Director, European Sales and Service, "In the last year, we have doubled the size of our European-based team. This gives us the ability to meet the needs of our expanding customer base and provide more Europe-specific support. We expect that last week's user group will be the first of many such successful events for our European customers."
Other news from the department research and development
